News

Evoke Pharma Scheduled to Release 2024 Annual Results Soon

Evoke Pharma Scheduled to Release 2024 Annual Results Soon

Evoke Pharma's Upcoming Financial Results Announcement

Evoke Pharma, Inc. (NASDAQ: EVOK), a dedicated pharmaceutical company focusing on treatments for gastrointestinal diseases, is preparing to share its financial performance for the fourth quarter and full year of 2024. The results are set to be released on Thursday, March 13, 2025, after market hours. This event marks a crucial moment for the company and its stakeholders.

Details of the Report Release

On the announcement date, Evoke Pharma will conduct a conference call alongside a live webcast at 4:30 p.m. ET. This event aims to provide a comprehensive review of the financial results, along with insights into the company’s future trajectory. Interested participants can join the call by dialing (800) 267-6316 for domestic callers or (203) 518-9783 for international attendees. Remember, the conference ID number for this call is EVOKQ424.

Continuing Commitment to Patient Care

Evoke Pharma stands at the forefront of innovation in the pharmaceutical field, concentrating on enhancing treatment options for patients burdened by gastrointestinal disorders. Their flagship product, Gimoti (metoclopramide) nasal spray, specifically targets the distress incurred by diabetic gastroparesis, a condition that affects the stomach's ability to process food properly. With Gimoti, patients enjoy the convenience of a nasal spray, enabling quicker relief compared to traditional oral and injectable medications.

The Impact of Diabetic Gastroparesis

Diabetic gastroparesis is a common yet often debilitating condition that affects numerous adults worldwide. Patients experience delayed gastric emptying, leading to significant discomfort and potential complications. By effectively addressing these symptoms, Evoke Pharma is making strides in enhancing the quality of life for those impacted. The unique delivery method of Gimoti through a nasal spray is a testament to Evoke’s innovative approach to gastrointestinal treatments.

Future of Evoke Pharma

The upcoming financial results will reflect not only past performances but also illuminate Evoke Pharma's strategic plans moving forward. This is an exciting time for the company, as it navigates the complex landscape of the pharmaceutical industry. Investors and analysts alike are eager to gauge the effectiveness of their marketing strategies and the overall demand for Gimoti in the current market.

Investor Relations and Communication

Evoke Pharma is committed to transparency and communication with its shareholders and potential investors. After the earnings call, executives will be available for further discussions, and a replay of the event will be accessible until March 20, 2025. The replay can be dialed through (800) 723-0544 for domestic callers and (402) 220-2656 for international participants. This initiative underlines Evoke’s dedication to keeping its audience informed and engaged.

About Evoke Pharma, Inc.

Evoke Pharma is a pioneering entity in the pharmaceutical industry with a specific focus on GI disorders. The company has successfully commercialized Gimoti, which is uniquely designed to mitigate the challenges associated with diabetic gastroparesis. With a rich pipeline of research and development initiatives, Evoke continues to strive for innovative treatments that can significantly alter the landscape of gastrointestinal disease management.

Contact Information

For media inquiries or more information about Evoke Pharma, please reach out to:

Daniel Kontoh-Boateng
DKB Partners
Phone: 862-213-1398
Email: dboateng@dkbpartners.net

Frequently Asked Questions

When will Evoke Pharma release its financial results?

Evoke Pharma is scheduled to announce its fourth quarter and full year 2024 results on March 13, 2025.

What is Gimoti?

Gimoti is a nasal spray formulation of metoclopramide developed by Evoke Pharma to treat symptoms associated with diabetic gastroparesis.

How can investors participate in the conference call?

Investors can join the conference call by dialing (800) 267-6316 for domestic callers or (203) 518-9783 for international participants.

Is there a replay available for the conference call?

Yes, a replay of the call will be available until March 20, 2025, using the replay numbers provided during the call.

Where can I find more information about Evoke Pharma?

More information can be found on Evoke Pharma's official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

RiskScout Rides High on Funding, Tackles Financial Crime

Updated Category News Views 4

A Fresh Injection to Combat Financial Crime Capital's flowing into RiskScout's coffers thanks to a new funding round, and it's not just about cash—it’s about gearing up for a battle against financial crime. The round was led by LiveOak Ventures, who aren't new to the block, alongside other players like Castle Creek Launchpad and Alloy Labs. After tripling their...

Continue Reading
Craig Hospital Expands: A Milestone for Rehab Care

Updated Category News Views 5

A Bold Step Forward in Neurorehabilitation Over a September sky in Englewood, Colorado, a ceremonial beam rose, marking a major milestone for Craig Hospital. It's not just steel and concrete; it's hope and progress for many who've found themselves at the mercy of neurological injuries. Celebrating the 'topping out' of their expanded campus, Craig's latest step forward...

Continue Reading
Appy Pie Secures Patent for AI Driven App Building

Updated Category News Views 2

A New Dawn in App Creation You ever think about a world where creating an app is as straightforward as chatting with an old buddy? Well, that future's knocking at the door, courtesy of Appy Pie. They're ruffling feathers with a shiny new U.S. patent promising just that—apps whipped into shape by a bit of chitchat with their AI-powered platform. It's got folks scratching...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
NUS Unveils eLuminator: A Leap for Robotics & Healthcare

Updated Category News Views 3

Game-Changing Electronic Skin From NUS It's not every day you come across tech that could shake up multiple industries, but that's just what the National University of Singapore has cooked up with their latest brainchild—the eLuminator. This ain't your everyday wearable tech. We're talking a skin-like device that can both detect and show touch in real-time, no fiddly...

Continue Reading
Schneider Electric Pushes Water Management Tech at WEFTEC

Updated Category News Views 6

Looks like Schneider Electric is diving headfirst into the choppy waters of utility management with its latest tech showcase at WEFTEC 2026. And trust me, the timing couldn't be more spot-on. With North America's water and wastewater systems groaning under the weight of aging infrastructure and cybersecurity threats, it’s about time someone brought something fresh to...

Continue Reading
Primrose Schools App: A Bold Step for Digital Literacy

Updated Category News Views 2

Primrose Schools Delivers a New Era in Child Education Sitting at a crossroads between the tactile charm of hands-on learning and the inevitable march of digital literacy, Primrose Schools has unveiled something that might just rock the boat in early education: their new Balanced Learning® App. This move by Primrose comes at a crucial time when many parents are...

Continue Reading
J.P. Morgan, Thunes Partner for Global Payment Integration

Updated Category News Views 3

You don't need a crystal ball to see J.P. Morgan's playing the long game by teaming up with Thunes. In this world, where cash is digital and the reach is global, it's all about speed and scale—brushing elbows with the right partners makes all the difference. Sometimes it's about knowing when to hitch your wagon to a reliable workhorse, especially when global commerce is...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 5

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Celina Graves Joins Expanding GoLive Streamers Platform

Updated Category News Views 3

Celina Graves Breaks New Ground on GoLive Streamers You'd think television capture all the talent buzz, but nope. Celina Graves, known from her semifinalist run on America's Got Talent, is diving into new waters by joining GoLive Streamers. She's stirring up the scene by making her performances more personal, stretching beyond the flatness of your typical TV appearance....

Continue Reading

Top 5 Most Recently Viewed Articles

B2Gold Successfully Closes Significant Offering of Convertible Notes

Updated Category News Views 192

B2Gold Successfully Closes Significant Offering of Convertible Notes VANCOUVER, British Columbia — B2Gold Corp. (NASDAQ: BTG, TSX: BTO, NSX: B2G) has successfully finalized its offering of 2.75% convertible senior unsecured notes due in 2030, totaling an impressive US$460 million. This offering was upsized from the original plan, demonstrating strong investor interest...

Continue Reading
First Headliners Announced for Texas Women Songwriters Festival

Updated Category News Views 126

Celebrating Female Musicians at the Upcoming Festival The Texas Women Songwriters Festival (TWSF) is gearing up for its inaugural event, showcasing an impressive lineup of headlining artists. This festival promises to be a celebration of women's contributions to music, featuring renowned musicians who have made their mark on the industry. Notable Headliners Announced...

Continue Reading
DIFC's Outstanding H1 2025 Performance Catalyzes Growth

Updated Category News Views 245

DIFC's Record-Breaking Performance in 2025 The Dubai International Financial Centre (DIFC), a prominent global financial hub, has showcased its impressive performance for the first half of the year 2025. This achievement not only strengthens DIFC's role in the economic landscape but also aligns with the ambitious Dubai Economic Agenda (D33), emphasizing the city’s...

Continue Reading
Nvidia's Future Looks Bright with AI and Accelerated Computing

Updated Category News Views 359

Nvidia's stock had a wild ride this year. If you tossed down $100 at the start of 2024, you’d be sitting on a staggering $830 today. That kind of surge doesn’t just happen; it’s largely thanks to Nvidia's pivotal role in the artificial intelligence (AI) boom. Analysts are already throwing around numbers like $800 a share by 2030, but let's not get ahead of...

Continue Reading
Anticipating Greenlight Capital Re's Q4 and Annual Results

Updated Category News Views 95

Greenlight Capital Re, Ltd. Plans Future Financial Release Greenlight Capital Re, Ltd. (NASDAQ: GLRE), a leading multiline property and casualty insurer and reinsurer, has announced its schedule for releasing financial results for the fourth quarter and full year, which ended on December 31, 2024. The company is set to disclose these important results after the market...

Continue Reading